GRAIL to Present at TD Cowen 45th Annual Health Care Conference
GRAIL (Nasdaq: GRAL), a healthcare company focused on early cancer detection, has announced its participation in the TD Cowen 45th Annual Health Care Conference. The company's management will deliver a presentation in Boston on Tuesday, March 4, 2025, at 9:10 a.m. ET.
Interested parties can access both live and replay webcasts through the investor relations section of GRAIL's website at investors.grail.com. The presentation recording will remain available for replay for a minimum of 30 days following the event.
GRAIL (Nasdaq: GRAL), un'azienda sanitaria focalizzata sulla rilevazione precoce del cancro, ha annunciato la sua partecipazione al 45° Convegno Annuale sulla Salute di TD Cowen. La direzione dell'azienda terrà una presentazione a Boston martedì 4 marzo 2025, alle 9:10 a.m. ET.
Le parti interessate possono accedere sia alla diretta che alle registrazioni delle webcasts attraverso la sezione delle relazioni con gli investitori del sito web di GRAIL all'indirizzo investors.grail.com. La registrazione della presentazione rimarrà disponibile per la visione per un minimo di 30 giorni dopo l'evento.
GRAIL (Nasdaq: GRAL), una empresa de atención médica enfocada en la detección temprana del cáncer, ha anunciado su participación en la 45ª Conferencia Anual de Salud de TD Cowen. La dirección de la empresa realizará una presentación en Boston el martes 4 de marzo de 2025, a las 9:10 a.m. ET.
Las partes interesadas pueden acceder tanto a las transmisiones en vivo como a las grabaciones a través de la sección de relaciones con inversores del sitio web de GRAIL en investors.grail.com. La grabación de la presentación estará disponible para su visualización durante un mínimo de 30 días después del evento.
GRAIL (Nasdaq: GRAL), 조기 암 검출에 초점을 맞춘 헬스케어 회사가 TD Cowen 제45회 연례 의료 회의에 참여한다고 발표했습니다. 회사 경영진은 2025년 3월 4일 화요일 오전 9시 10분(동부 표준시)에 보스턴에서 발표를 진행할 예정입니다.
관심 있는 분들은 GRAIL 웹사이트의 투자자 관계 섹션을 통해 실시간 및 재생 웹캐스트에 접근할 수 있습니다. 발표 녹화는 이벤트 이후 최소 30일 동안 재생 가능할 것입니다.
GRAIL (Nasdaq: GRAL), une entreprise de santé axée sur la détection précoce du cancer, a annoncé sa participation à la 45ème Conférence Annuelle sur la Santé de TD Cowen. La direction de l'entreprise fera une présentation à Boston le mardi 4 mars 2025, à 9h10 ET.
Les parties intéressées peuvent accéder aux webdiffusions en direct et aux rediffusions via la section des relations avec les investisseurs du site web de GRAIL à l'adresse investors.grail.com. L'enregistrement de la présentation restera disponible en replay pendant un minimum de 30 jours après l'événement.
GRAIL (Nasdaq: GRAL), ein Gesundheitsunternehmen, das sich auf die frühe Erkennung von Krebs spezialisiert hat, hat seine Teilnahme an der 45. jährlichen Gesundheitskonferenz von TD Cowen bekannt gegeben. Das Management des Unternehmens wird am Dienstag, den 4. März 2025, um 9:10 Uhr ET in Boston eine Präsentation halten.
Interessierte Parteien können sowohl Live- als auch Wiederholungs-Webcasts über den Bereich für Investorenbeziehungen auf der Website von GRAIL unter investors.grail.com abrufen. Die Aufzeichnung der Präsentation bleibt für mindestens 30 Tage nach der Veranstaltung verfügbar.
- None.
- None.
Live and replay webcasts may be accessed in the investor relations section of GRAIL's website at investors.grail.com. The webcast will be archived and available for reply for at least 30 days after the event.
About GRAIL
GRAIL is a healthcare company whose mission is to detect cancer early, when it can be cured. GRAIL is focused on alleviating the global burden of cancer by using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. GRAIL's targeted methylation-based platform can support the continuum of care for screening and precision oncology, including multi-cancer early detection in symptomatic patients, risk stratification, minimal residual disease detection, biomarker subtyping, treatment and recurrence monitoring. GRAIL is headquartered in
For more information, visit grail.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/grail-to-present-at-td-cowen-45th-annual-health-care-conference-302381977.html
SOURCE GRAIL, Inc.
FAQ
When is GRAIL (GRAL) presenting at the TD Cowen Healthcare Conference 2025?
How can investors watch GRAIL's presentation at the TD Cowen Conference?
How long will GRAIL's TD Cowen Conference presentation replay be available?
What is the focus of GRAIL's (GRAL) business mission?
